-
1
-
-
33344461525
-
Ambulatory care visits to physician offices, hospital outpatient departments, and emergercy departments: United States, 2001-02
-
Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergercy departments: United States, 2001-02. Vital Health Stat 13 2006; 1-66.
-
(2006)
Vital Health Stat
, vol.13
, pp. 1-66
-
-
Schappert, S.M.1
Burt, C.W.2
-
2
-
-
25844526549
-
Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004
-
Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005; 6:662-672.
-
(2005)
J Pain
, vol.6
, pp. 662-672
-
-
Cicero, T.J.1
Inciardi, J.A.2
Munoz, A.3
-
3
-
-
0034720813
-
Deafness associated with abuse of hydrocodone/acetaminophen
-
Oh AK, Ishiyama A, Baloh RW. Deafness associated with abuse of hydrocodone/acetaminophen. Neurology 2000; 54:2345.
-
(2000)
Neurology
, vol.54
, pp. 2345
-
-
Oh, A.K.1
Ishiyama, A.2
Baloh, R.W.3
-
4
-
-
0034010931
-
Profound hearing loss associated with hydrocodone/acetaminophen abuse
-
Friedman RA, House JW, Luxford WM, Gherini S, Mills D. Profound hearing loss associated with hydrocodone/acetaminophen abuse. Am J Otol 2000; 21:188-191.
-
(2000)
Am J Otol
, vol.21
, pp. 188-191
-
-
Friedman, R.A.1
House, J.W.2
Luxford, W.M.3
Gherini, S.4
Mills, D.5
-
5
-
-
0025909040
-
Complete nerve deafness after abuse of co-proxamol
-
Ramsey BC. Complete nerve deafness after abuse of co-proxamol. Lancet 1991; 338:446-447.
-
(1991)
Lancet
, vol.338
, pp. 446-447
-
-
Ramsey, B.C.1
-
6
-
-
0018017235
-
Total deafness with chronic propoxyphene abuse
-
Harell M, Shea JJ, Emmett JR. Total deafness with chronic propoxyphene abuse. Laryngoscope 1978; 88:1518-1521.
-
(1978)
Laryngoscope
, vol.88
, pp. 1518-1521
-
-
Harell, M.1
Shea, J.J.2
Emmett, J.R.3
-
7
-
-
0017297269
-
Inner ear damage related to propoxyphene ingestion
-
Lupin AJHS. Inner ear damage related to propoxyphene ingestion. Can Med Assoc J 1976; 114:596.
-
(1976)
Can Med Assoc J
, vol.114
, pp. 596
-
-
Lupin, A.J.H.S.1
-
8
-
-
0028206673
-
Sudden hearing loss associated with interferon
-
Kanda Y, Shigeno K, Kinoshita N, Nakao K, Yano M, Matsuo, H. Sudden hearing loss associated with interferon. Lancet 1994; 343:1134-1135.
-
(1994)
Lancet
, vol.343
, pp. 1134-1135
-
-
Kanda, Y.1
Shigeno, K.2
Kinoshita, N.3
Nakao, K.4
Yano, M.5
Matsuo, H.6
-
9
-
-
2942679617
-
Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin
-
Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004; 99:873-877.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 873-877
-
-
Formann, E.1
Stauber, R.2
Denk, D.M.3
Jessner, W.4
Zollner, G.5
Munda-Steindl, P.6
Gangl, A.7
Ferenci, P.8
-
10
-
-
0021246193
-
Sudden hearing loss: Eight years' experience and suggested prognostic table
-
Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984; 94(5 Pt 1):647-661.
-
(1984)
Laryngoscope
, vol.94
, Issue.5 PART 1
, pp. 647-661
-
-
Byl Jr., F.M.1
-
11
-
-
0016927144
-
Sudden sensorineural hearing impairment: A report of 1,220 cases
-
Shaia FT, Sheehy JL. Sudden sensorineural hearing impairment: a report of 1,220 cases. Laryngoscope. 1976; 86(3):389-398.
-
(1976)
Laryngoscope
, vol.86
, Issue.3
, pp. 389-398
-
-
Shaia, F.T.1
Sheehy, J.L.2
-
12
-
-
0037115525
-
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs
-
Rogers JF, Nafziger AN, Bertino IS, Jr. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. Am J Med 2002; 113:746-750.
-
(2002)
Am J Med
, vol.113
, pp. 746-750
-
-
Rogers, J.F.1
Nafziger, A.N.2
Bertino Jr., I.S.3
-
13
-
-
0025853291
-
Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers
-
Chen ZR, Somogyi AA, Reynolds G, Bochner F. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br J Clin Pharmacol 1991; 31:381-390.
-
(1991)
Br J Clin Pharmacol
, vol.31
, pp. 381-390
-
-
Chen, Z.R.1
Somogyi, A.A.2
Reynolds, G.3
Bochner, F.4
-
14
-
-
0025830147
-
Mu receptor binding of some commonly used opioids and their metabolites
-
Chen ZR, Irvine RJ, Somogyi AA, Bochner F. Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 1991; 48:2165-2171.
-
(1991)
Life Sci
, vol.48
, pp. 2165-2171
-
-
Chen, Z.R.1
Irvine, R.J.2
Somogyi, A.A.3
Bochner, F.4
-
15
-
-
1542359666
-
CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes
-
Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. Br J Clin Pharmacol 2004; 57:287-297.
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 287-297
-
-
Hutchinson, M.R.1
Menelaou, A.2
Foster, D.J.3
Coller, J.K.4
Somogyi, A.A.5
-
16
-
-
0036825844
-
Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: Genotyping cytochrome P450 2D6 for oxycodone cases
-
Jannetto PJ, Wong SH, Gock SB, Laleli-Sahin E, Schur BC, Jentzen JM. Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases. J Anal Toxicol 2002:26:438-447.
-
(2002)
J Anal Toxicol
, vol.26
, pp. 438-447
-
-
Jannetto, P.J.1
Wong, S.H.2
Gock, S.B.3
Laleli-Sahin, E.4
Schur, B.C.5
Jentzen, J.M.6
-
17
-
-
0042634370
-
Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers
-
de Leon J, Dinsmore L, Wedlund P. Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers. J Clin Psychopharmacol 2003; 23:420-421.
-
(2003)
J Clin Psychopharmacol
, vol.23
, pp. 420-421
-
-
de Leon, J.1
Dinsmore, L.2
Wedlund, P.3
-
18
-
-
1942469598
-
Characterization of the acetaminophen-induced degradation of cytochrome P450-3A4 and the proteolytic pathway
-
Zhang QX, Melnikov Z, Feierman DE. Characterization of the acetaminophen-induced degradation of cytochrome P450-3A4 and the proteolytic pathway. Basic Clin Pharmacol Toxicol 2004; 94:191-200.
-
(2004)
Basic Clin Pharmacol Toxicol
, vol.94
, pp. 191-200
-
-
Zhang, Q.X.1
Melnikov, Z.2
Feierman, D.E.3
-
19
-
-
15544372202
-
Autoantibodies and autoantigens in autoimmune hepatitis: Important tools in clinical practice and to study pathogenesis of the disease
-
Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 2004; 1:2.
-
(2004)
J Autoimmune Dis
, vol.1
, pp. 2
-
-
Zachou, K.1
Rigopoulou, E.2
Dalekos, G.N.3
-
20
-
-
0037677544
-
The presence of opioid receptors in rat inner ear
-
Jongkamonwiwat N, Phansuwan-Pujito P, Sarapoke P, Chetsawang B, Casalotti SO, Forge A, Dodson H, Govitrapong P. The presence of opioid receptors in rat inner ear. Hear Res 2003; 181:85-93.
-
(2003)
Hear Res
, vol.181
, pp. 85-93
-
-
Jongkamonwiwat, N.1
Phansuwan-Pujito, P.2
Sarapoke, P.3
Chetsawang, B.4
Casalotti, S.O.5
Forge, A.6
Dodson, H.7
Govitrapong, P.8
-
21
-
-
5444243356
-
Expression and distribution of mu opioid receptors in the inner ear of the rat
-
Popper P, Cristobal R, Wackym PA. Expression and distribution of mu opioid receptors in the inner ear of the rat. Neuroscience 2004; 129:225-233.
-
(2004)
Neuroscience
, vol.129
, pp. 225-233
-
-
Popper, P.1
Cristobal, R.2
Wackym, P.A.3
|